dentapress Logo

dentapress Premium

Use the dentapress- network to publish your product- news in the internet.
dentapress Logo

dentapress Premium

Use the dentapress- partnerservice to encourage your comany- profile within the target group.
Posted at Sep 11, 2014 by MG

In vivo osteoprotegerin gene therapy preventing bone loss induced by periodontitis » onlinelibrary.wiley.com

Share on Facebook  |  Share on zahnigroups  |  Share on ALUMNIGROUPS

Conclusion
Local recombinant OPG plasmid-mediated gene therapy suppresses osteoclastogenesis in vivo and inhibits alveolar bone height reduction caused by experimental periodontitis in rats. OPG gene therapy may be beneficial in preventing progressive periodontal bone loss.

Read more:
http://onlinelibrary.wiley....8B25908DB4376111F53730B.f02t04

« HEADLINES « Science
+++ dentapress Partner ALUMNIGROUPS